HCBP6 Modulates Triglyceride Homeostasis in Hepatocytes Via the SREBP1c/FASN Pathway

Journal of Cellular Biochemistry

Volumn 116, Issue 10, 2015, Pages 2375-2384

  Gao, Li Li ^a,b   Li, Min ^c   Wang, Qi ^a,b   Liu, Shun Ai ^a,b   Zhang, Jin Qian ^a,b   Cheng, Jun ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Key Laboratory of Emerging Infectious Diseases   (China)

^c LANZHOU UNIVERSITY   (China)

Author keywords

FATTY ACID; GENE EXPRESSION; LIPASE HEPATIC; MicroRNA 122; NUCLEAR RECEPTORS SREBP; TRIGLYCERIDES

Indexed keywords

BINDING PROTEIN; FATTY ACID SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPATITIS C VIRUS CORE BINDING PROTEIN 6; LUCIFERASE; MESSENGER RNA; MICRORNA 122; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CORE PROTEIN; FASN PROTEIN, HUMAN; MICRORNA; MIRN122 MICRORNA, HUMAN; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

3' UNTRANSLATED REGION; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; FATTY LIVER; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEPACIVIRUS; LIVER; METABOLISM; PATHOGENICITY; PATHOLOGY; SIGNAL TRANSDUCTION; VIROLOGY;

HEPATITIS C VIRUS;

FATTY ACID SYNTHASE, TYPE I; FATTY LIVER; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATOCYTES; HOMEOSTASIS; HUMANS; LIVER; MICRORNAS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES; VIRAL CORE PROTEINS;

EID: 84939187279     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25188     Document Type: Article

References (50)

1. Androsavich JR, Chau BN,. 2014. Non-inhibited miRNAs shape the cellular response to anti-miR. Nucleic Acids Res 42: 6945-6955.
2. Anstee QM, Targher G, Day CP,. 2013. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10: 330-344.
3. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T, Bréchot C,. 1997. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94: 1200-1205.
4. Bartel DP,. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
5. Bengoechea-Alonso MT, Punga T, Ericsson J,. 2005. Hyperphosphorylation regulates the activity of SREBP1 during mitosis. Proc Natl Acad Sci USA 102: 11681-11686.
6. Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel G, Bjørge T, Manjer J, Hallmans G, Selmer R, Almquist M, Häggström C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P, Ulmer H,. 2011. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control 22: 291-299.
7. Brown MS, Goldstein JL,. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340.
8. Brown MS, Goldstein JL,. 2009. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J Lipid Res 50 Suppl: S15-S27.
9. Browning JD, Horton JD,. 2004. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114: 147-152.
10. Cha JY, Repa JJ,. 2007. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 282: 743-751.
11. Choi SH, Ginsberg HN,. 2011. Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance. Trends Endocrinol Metab 22: 353-363.
12. Dharancy S, Malapel M, Perlemuter G, Roskams T, Cheng Y, Dubuquoy L, Podevin P, Conti F, Canva V, Philippe D, Gambiez L, Mathurin P, Paris JC, Schoonjans K, Calmus Y, Pol S, Auwerx J, Desreumaux P,. 2005. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 128: 334-342.
13. Duncan RE, Archer MC,. 2008. Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytes. Lipids 43: 619-627.
14. Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F,. 2004. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 86: 839-848.
15. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, Subramaniam A, Propp S, Lollo BA, Freier S, Bennett CF, Bhanot S, Monia BP,. 2006. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98.
16. Fabbrini E, Sullivan S, Klein S,. 2010. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 51: 679-689.
17. Goldberg IJ., 2001. Clinical review 124: Diabetic dyslipidemia: Causes and consequences. J Clin Endocrinol Metab 86: 965-971.
18. Goldstein JL, DeBose-Boyd RA, Brown MS,. 2006. Protein sensors for membrane sterols. Cell 124: 35-46.
19. Gomez-Lechon MJ, Donato MT, Martinez-Romero A, Jimenez N, Castell JV, O'Connor JE,. 2007. A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact 165: 106-116.
20. Horton JD, Goldstein JL, Brown MS,. 2002. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109: 1125-1131.
21. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581.
22. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J,. 2007. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 355: 883-888.
23. Koo SH., 2013. Nonalcoholic fatty liver disease: Molecular mechanisms for the hepatic steatosis. Clin Mol Hepatol 19: 210-215.
24. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M,. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
25. Krycer JR, Sharpe LJ, Luu W, Brown AJ,. 2010. The Akt-SREBP nexus: Cell signaling meets lipid metabolism. Trends Endocrinol Metab 21: 268-276.
26. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T,. 2002. Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739.
27. Li K, Wang L, Cheng J, Zhang L, Duan H, Lu Y, Yang J, Liu Y, Xia X, Wang G, Dong J, Li L, Zhong Y, Hong Y, Chen J,. 2002. Screening and cloning gene of hepatocyte protein interacting with hepatitis C virus core protein. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 16: 351-353.
28. Liu M, Liu Y, Cheng J, Zhang SL, Wang L, Shao Q, Zhang J, Yang Q,. 2004. Transactivating effect of hepatitis C virus core protein: a suppression subtractive hybridization study. World J Gastroenterol 10: 1746-1749.
29. Matsumoto M, Ogawa W, Teshigawara K, Inoue H, Miyake K, Sakaue H, Kasuga M,. 2002. Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. Diabetes 51: 1672-1680.
30. Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, Murata S, Tanaka K, Miyamura T, Suzuki T, Koike K, Matsuura Y,. 2007. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA 104: 1661-1666.
31. Nakakuki M, Kawano H, Notsu T, Imada K, Mizuguchi K, Shimano H,. 2014. A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid. J Biochem 155: 301-313.
32. Nordestgaard BG, Varbo A,. 2014. Triglycerides and cardiovascular disease. Lancet 384: 626-635.
33. Novak J, Bienertova-Vasku J, Kara T, Novak M,. 2014. MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment. Mediators Inflamm 2014: 275867.
34. Ono H, Shimano H, Katagiri H, Yahagi N, Sakoda H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Viana AY, Fukushima Y, Abe M, Shojima N, Kikuchi M, Yamada N, Oka Y, Asano T,. 2003. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52: 2905-2913.
35. Perlemuter G, Sabile A, Letteron P, Vona G, Topilco A, Chrétien Y, Koike K, Pessayre D, Chapman J, Barba G, Bréchot C,. 2002. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: A model of viral-related steatosis. FASEB J 16: 185-194.
36. Postic C, Girard J,. 2008. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: Lessons from genetically engineered mice. J Clin Invest 118: 829-838.
37. Semenkovich CF., 1997. Regulation of fatty acid synthase (FAS). Prog Lipid Res 36: 43-53.
38. Shao W, Espenshade PJ,. 2012. Expanding roles for SREBP in metabolism. Cell Metab 16: 414-419.
39. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL,. 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99: 846-854.
40. Shimano H,. 2001. Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40: 439-452.
41. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, Moriya K, Koike K,. 2004. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 126: 840-848.
42. Siri P, Candela N, Zhang YL, Ko C, Eusufzai S, Ginsberg HN, Huang LS,. 2001. Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance. J Biol Chem 276: 46064-46072.
43. Sone H, Tanaka S, Tanaka S, Iimuro S, Ishibashi S, Oikawa S, Shimano H, Katayama S, Ohashi Y, Akanuma Y, Yamada N, Japan Diabetes Complications Study Group. 2012. Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: Subanalysis of the Japan Diabetes Complications Study. Diabetes Care 35: 1150-1157.
44. Taghibiglou C, Martin HG, Lai TW, Cho T, Prasad S, Kojic L, Lu J, Liu Y, Lo E, Zhang S, Wu JZ, Li YP, Wen YH, Imm JH, Cynader MS, Wang YT,. 2009. Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med 15: 1399-1406.
45. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP,. 2009. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582.
46. Wang L, Cheng J, Li K, Hong Y,. 2006. Identification and evaluation promoter sequence and the transcription activation of Hcbp6 interaction with core protein of hepatitis C virus. Zhonghua Gan Zang Bing Za Zhi 14: 81-85.
47. Wang R, Kong X, Cui A, Liu X, Xiang R, Yang Y, Guan Y, Fang F, Chang Y,. 2010. Sterol-regulatory-element-binding protein 1c mediates the effect of insulin on the expression of Cidea in mouse hepatocytes. Biochem J 430: 245-254.
48. Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, Wu E, Ye X, Gao GF, Wang F, Chen Y, Duan Z, Meng S,. 2012. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Hepatology 55: 730-741.
49. Yahagi N, Shimano H, Hasegawa K, Ohashi K, Matsuzaka T, Najima Y, Sekiya M, Tomita S, Okazaki H, Tamura Y, Iizuka Y, Ohashi K, Nagai R, Ishibashi S, Kadowaki T, Makuuchi M, Ohnishi S, Osuga J, Yamada N,. 2005. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 41: 1316-1322.
50. Yang Z, Liu Z, Cheng J, Wang JJ, Hong Y, Zhang S,. 2003. Up-regulating effect of human hepatitis C virus core protein-binding protein 6 on NACA promoter. World Chin J Digestol 11: 959-962.